BUSINESS COMBINATIONS - Pro Forma Information (Details) - GeneSiC $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($) $ / shares
Business Acquisition [Line Items]
Revenue | $	$ 11,476
Net income | $	$ 79,741
Basic net income per share (in dollars per share) | $ / shares	$ 0.55
Diluted net income per share (in dollars per share) | $ / shares	$ 0.51